MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by the accumulation of abnormal proteins, including beta-amyloid (Aβ) and tau in the brain, leading to the formation of amyloid plaques and neurofibrillary tangles and then to the progressive decline of cognitive function [1].